From Concept to Medicine - A Comprehensive Drug Development Journey

This episode provides a comprehensive recap of the key concepts covered in Season 3, focusing on preclinical pharmacokinetics and setting the stage for the exciting transition to human testing in clinical trials. We'll revisit essential terms like volume of distribution, elimination half-life, clearance, and absorption, reinforcing their importance in understanding how drugs behave in the body. We...

Dive into the essential world of risk management in the preclinical phase of drug development. This episode explores how scientists identify, assess, and mitigate risks before a new drug is even tested in humans. We'll discuss the use of risk matrices and decision frameworks, highlighting their strengths and limitations in visualizing and prioritizing risks. Using real-world case studies, includin...

This episode explores the crucial process of integrating preclinical data to create a compelling IND application, the gateway to human clinical trials. We delve into how toxicology, PK, and efficacy data are synthesized into a cohesive narrative that tells the complete story of a drug. We'll discuss the importance of data integration, highlighting how different pieces of the puzzle fit together to...

Dive into a real-world success story of a drug that navigated the challenging preclinical phase and achieved the milestone of a successful IND submission. This episode offers an inside look at the strategies that helped this drug overcome obstacles, highlighting the power of scientific ingenuity, meticulous research, and collaboration. We'll explore the crucial role of pharmacokinetics in drug dev...

Explore the crucial, often unseen world of preclinical regulatory interactions, where communication between drug developers and regulatory agencies like the FDA and ICH can make or break a new drug's success. This episode focuses on how early meetings with regulators shape study design, data requirements, and ultimately, the entire drug development process. We'll discuss the importance of seeking...

Dive into the complex world of immunogenicity assessment in biologics, exploring how our immune systems interact with these advanced medications derived from living organisms. This episode focuses on the challenges of immunogenicity, where our bodies can react to biologics as foreign substances, potentially impacting treatment effectiveness and causing unwanted side effects. We'll explore the soph...

This episode focuses on the crucial role of stability testing in the preclinical phase of drug development, ensuring a drug candidate's integrity throughout its journey from the lab to the patient. We explore how drugs are subjected to various stress tests, mimicking real-world conditions like temperature swings, humidity, and light exposure, and how these tests help determine the drug's shelf lif...

Explore the fascinating world of bioanalytical method development, where scientists devise incredibly precise methods to measure drug levels in biological samples. This episode focuses on developing highly sensitive assays for PK and safety studies, enabling researchers to track a drug's journey through the body and monitor its safety profile. We'll discuss key concepts like accuracy, precision, s...

Venture behind the scenes of early-stage drug development and explore the often-overlooked but critical world of Chemistry, Manufacturing, and Controls (CMC). This episode focuses on the preclinical CMC work that ensures a drug candidate not only works but can be consistently manufactured at scale. We delve into the challenges of lab-scale synthesis, such as the availability and cost of starting m...

This episode provides a comprehensive overview of the studies required to support an Investigational New Drug (IND) application, the crucial step that takes a new drug from the lab to human trials. We focus on the three main pillars: toxicology, pharmacokinetics (PK), and efficacy. Toxicology studies ensure the drug's safety, PK studies track its journey through the body, and efficacy studies demo...

Uncover the crucial role of preclinical efficacy models in demonstrating a drug candidate's potential before human trials even begin. This episode explores both in vivo (animal) and in vitro (laboratory) models, highlighting the strengths and limitations of each approach. We delve into the complexities of model selection, considering factors like the disease being targeted and the drug's mechanism...

This episode explores the critical process of determining the right dose for a new drug, a delicate balance between effectiveness and safety. We focus on dose-range finding studies in animal models, where researchers seek that "sweet spot"—a dose that works without causing harmful side effects. We'll discuss various dosing schedules, from single-dose studies for initial understanding to repeated-d...

Dive into the critical realm of early safety testing in drug development, focusing on safety pharmacology and off-target screening. This episode explores how scientists identify and mitigate potential risks associated with new drugs before they even reach human trials. We'll discuss essential safety assays like the hERG assay for heart risks and liver enzyme assays for liver toxicity. We'll also e...

Explore the fascinating world of pharmacokinetics (PK) in preclinical testing, where scientists unravel the mysteries of a drug's journey through the body. We focus on ADME studies—absorption, distribution, metabolism, and excretion—conducted in animal models, providing crucial insights for predicting human doses. This episode delves into the experimental techniques used to track a drug's movement...

Delve into the critical world of preclinical toxicology studies, the essential stepping stone before a new drug can even be considered for human trials. These studies, encompassing acute, subchronic, and chronic designs, are the bedrock of ensuring drug safety, identifying potential hazards early on. We'll explore how scientists use these studies to evaluate a drug's safety profile, examining the...

This episode recaps the entire journey covered in Season 2, from target selection to candidate nomination, reinforcing key concepts for future phases. The discussion will integrate lessons learned from past failures and preview the complexities of preclinical development that will be explored in Season 3. This episode serves as a valuable review and sets the stage for the next chapter in the drug...

This episode outlines the critical steps involved in ramping up from candidate selection to comprehensive IND-enabling studies. We will discuss the process of scaling up preclinical work, manufacturing pilot batches, and preparing the necessary regulatory dossiers. The conversation will also explore how regulatory strategy influences preclinical plans, providing real-world literature examples from...

This episode explores the crucial process of selecting the best drug candidate from a pool of optimized leads. We'll discuss the criteria used by research teams, including efficacy, safety, and manufacturability. The conversation will focus on data-driven candidate selection, using case studies to illustrate the decision-making process. Economic and business considerations, such as market exclusiv...

This episode focuses on the critical role of early safety testing in drug development. We'll explain key tests like the hERG inhibition assay, which helps identify potential cardiac risks. We will discuss assay design, providing examples like the history of terfenadine and the importance of early toxicological profiling. The episode will also explore AI-driven toxicity prediction models and examin...

This episode delves into the common hurdles encountered in early drug discovery, such as false positives, synthetic challenges, and assay artifacts. We'll discuss troubleshooting strategies and how scientists adapt their screening methods based on actual lab data. Examples of failed high-profile drug candidates will be used to illustrate these hurdles and the lessons learned from these setbacks. T...

This episode follows the journey of an HIV protease inhibitor as a real-world example, tying together key drug discovery steps. We'll use this case study to illustrate target validation, design, and lead optimization, providing detailed literature references. The episode will also include a parallel failed drug in the same area, contrasting what worked versus what didn't. This episode provides a c...

This episode showcases the important role nature plays in drug discovery, using examples like penicillin and taxol. We'll discuss the subsequent chemical optimization of these natural products and how scientists are harnessing these complex compounds for modern therapeutic use. We will address why natural products are underutilized today and explore strategies to revitalize natural compound screen...

This episode focuses on early assessments of absorption, distribution, metabolism, and excretion (ADME) in drug development. We will discuss how these assessments ensure that drug candidates are "drug-like" and explore Lipinski's Rule of 5 as a key guiding principle. Real-world examples of ADME screening in practice will be provided, along with exceptions to Lipinski's rule, particularly for biolo...

This episode provides a foundational understanding of structure-activity relationships (SAR) in medicinal chemistry. We will explore how systematic chemical changes inform potency and selectivity of drug candidates. The conversation will cover SAR data, reaction mechanisms, and how adjustments are made based on real experimental outcomes. Modern techniques like AI-driven SAR modeling will be intro...

This episode describes the iterative process of refining "hits" into promising "leads" in drug discovery. We will explore how scientists balance potency, safety, and drug-like properties while making successive chemical modifications. The concept of structure-activity relationships (SAR) will be central to the discussion. We'll also integrate a case study, such as the development of SARS-CoV-2 ant...